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Summary
Objective: Synthesis rates of aggrecans by phenotypically stable human articular chondrocytes and the immobilization of these aggrecans
in large aggregates were used as variables reflecting the capability of these cells of restoring the extracellular matrix of articular cartilage in
vivo in an aging population.
Design: Human articular chondrocytes were isolated from articular cartilage obtained from 33 different donors at autopsy. The chondrocytes
were cultured in gelled agarose. Synthesis of aggrecans was investigated using Na235SO4 as a radioactive precursor after a 2-week culture
period. Electron microscopic study of aggrecan aggregates was done on the macromolecules accumulated over 3 weeks in culture by the
chondrocytes obtained from eight other donors with increasing ages.
Results: Sulfate incorporation rates into aggrecans correlated inversely with the age of the donor. The value of sulfate incorporation in
aggrecans for chondrocytes obtained from mature cartilage of a 20-year-old individual in this system drops to 50% and 25% for chondrocytes
obtained from 45- and 69-year-old individuals respectively. Electron microscopic study of aggrecan aggregates showed that the ‘de novo’
synthesized hyaluronan molecules were fully loaded with aggrecans. Mature human articular cartilage cells were found to synthesize an
aggrecan aggregate which carried an average number of 11.7 to 13.1 aggrecans. Cells obtained from immature donors synthesized
aggrecan aggregates of which the hyaluronan chain carried twice the amount of aggrecans. These immature human articular cartilage cells
were also found to synthesize significant proportions of large aggrecan aggregates with 20 to over 100 aggrecans immobilized on a single
hyaluronan chain. The proportions of these large aggrecan aggregates decreased with increasing age of the donors of the chondrocytes.
Conclusion: The declining aggrecan synthesis rates and the decreased capability of assembling large molecular size aggregates with
increasing age in humans illustrates a progressive failure of the repair function of articular cartilage cells in humans. © 2000 OsteoArthritis
Research Society International
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Cartilage tissue resistance against compressive stress is
ascertained by the proteoglycans of the extracellular
matrix. The main proteoglycan population in hyaline articu-
lar cartilage consists of aggrecans which are synthesized
by the chondrocytes and form huge molecular aggre-
gates with hyaluronan. By virtue of their molecular size,
these aggregates remain immobilized in the immediate
environment of the cell.
Literature data suggest that proteoglycan synthesis rates
and turnover by articular chondrocytes of different carti-
lages decline in mature cartilage.1–4 There is a continuous
reduction in size, buoyant density and chondroitinsulfate
content of the monomeric aggrecan with aging in mature
cartilage in humans and other species.5–10 These observa-
tions indicate that articular cartilage chondrocyte metab-
olism and the quality of the aggrecan change during adult
life.170Electron microscopic studies comparing aggrecan
aggregates isolated from mature and immature bovine
cartilage showed large differences in the molecular sizes of
the two aggrecan aggregate populations. Large aggregates
were mainly found in immature tissues from calves. Small
aggregates were predominantly present in adult steer
cartilage.8,10 The age-related changes in the hydrodynamic
size of the aggregate were mainly attributed to the length of
the hyaluronan backbone and the spacing between the
aggrecan monomers on that hyaluronan filament.8,10,11
However, these aggregates were studied after reassocia-
tion of the respective components following their isolation in
dissociative conditions. Especially where spacing between
aggrecan monomers on the hyaluronan backbone is con-
cerned, it is difficult to rule out some artefactual changes
after reassociation in vitro.
Recently, native aggrecan aggregates, which were syn-
thesized by phenotypically stable differentiated chondro-
cytes cultured in agarose gels, were studied by electron
microscopy. These aggrecan aggregates were obtained
following solubilization of the artificial extracellular agarose
matrix with agarase. It was shown that this digestion
procedure did not affect the structure of the aggregate and
enabled the native aggregate to be studied.12,13 In the
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nan chain were observed. Large amounts of free non-
aggregated monomeric aggrecans observed probably
exceeded the space available on the hyaluronan back-
bone. Consequently, the length of the hyaluronan chain
defined the molecular size of the aggregate.
The average aggrecan aggregate, synthesized by
chondrocytes isolated from visually intact mature cartilage,
carried about 12 aggrecans. However, mature human
articular cartilage cells were found to synthesize small
proportions of large aggrecan aggregates with 20 to over
100 aggrecans attached to a single hyaluronan chain.
This study concentrates on the differences in aggrecan
synthesis rates and aggrecan aggregate assembly in
articular cartilage obtained from human donors at different
ages.Material and methods
HUMAN ARTICULAR CHONDROCYTES
Human articular chondrocytes were isolated as
described elsewhere,14,15 with a few modifications. Articu-
lar cartilage was obtained at autopsy from different donors
within 24 hours post mortem. All donors had died after a
short illness. None of them had been receiving cortico-
steroids or cytostatic drugs. Visually intact cartilage was
sampled from the femur condyles, diced into small frag-
ments and digested in a spinner bottle. All enzymatic
solutions were made in Dulbecco’s modified Eagle’s
medium (DMEM; GIBCO) with antibiotics and antimycotics
(penicillin 10 U/ml; streptomycin 10 mg/ml; fungizone
0.025 mg/ml; GIBCO), 0.002 M/ml L-glutamine and 10% of
fetal calf serum when specified.
Articular cartilage was treated with 0.25% of sheep
testes hyaluronidase (Sigma) in DMEM for 120 min at
37°C. The hyaluronidase solution was then replaced by
0.25% of Pronase (Streptomyces griseus Pronase E;
Sigma) in DMEM for 90 min at 37°C. The cartilage was
then washed twice with DMEM containing 10% of FCS and
stored overnight in the same incubation medium at 37°C.
The tissue was solubilized next day following a 3 to 6 hours’
0.25% collagenase (Clostridium histolyticum; Sigma) treat-
ment in DMEM with 10% FCS at 37°C. Cells were then
centrifuged for 10 min at 800 g, washed three times with
DMEM with FCS, tested for viability (Trypan Blue exclusion
test) and counted. More than 95% of the cells were usually
viable after isolation.CHONDROCYTES IN AGAROSE CULTURE
Chondrocytes were cultured in gelled agarose, as pre-
viously described16 with some modifications.13,17 The cul-
tures were set up in 3.8 ml cryotubes (NUNC). The agarose
used was ultralow gelling temperature agarose (Type IX,
gelling at <15°C and remelting at <50°C, SIGMA) for the
simple reason that this agarose is easy to work with at
room temperature. Three % agarose in distilled water was
autoclaved twice for 15 min and stored at 4–8°C prior to
use. The cryotubes were coated with 100 l of this 3%
agarose and the coating was then allowed to gel at 4–8°C.
Chondrocyte suspension cultures were established in 1.5%
agarose concentrations. Three % (double concentrated)
agarose gel was melted before use, kept at 37°C and
mixed with an equal volume of 2×DMEM (for 50 ml of
2×DMEM: 1.337 g of lyophilized DMEM, 0.37 g NaHCO3and 10 mg of ascorbate in 40 ml distilled water and 10 ml
FCS; to sterilize through a 0.22 m pore membrane filter)
with 20% of FCS to give the desired concentration of
agarose in DMEM with 10% of FCS.
0.1 vol of the chondrocyte suspension was added to
1 vol of soluble agarose in DMEM. Coated cryotubes were
filled with 300 l of chondrocytes/agarose suspension and
kept at 4–8°C for 15 min to allow the agarose to gel. The
final cell density was approx. 1.5×106 chondrocytes per
culture. Three ml of the appropriate incubation medium
were then added and the cultures were placed in an
incubator at 37°C under 5% CO2 for 2 weeks. Nutrient
medium plus 50 g per ml of freshly dissolved ascorbate
was replaced three times weekly.
Chondrocyte survival and proliferation in agarose was
followed by measurement of the DNA content in the
chondrocyte cultures obtained from six donors ranging
between 0 and 61 years of age. With the exception of one
donor of whom the cells were cultured in 0.5 and 1.5% of
agarose, all cultures were made in 1.5% of agarose. From
each donor, four cultures were stored at −20°C immedi-
ately after the gelling of the agarose and after 1 and
2 weeks of culture. DNA content was assayed as
described18 using the enhancement of fluorescence of
trisbenzimidazole (Hoechst 33258) when the latter binds to
double stranded DNA.19 The agarose cultures were there-
fore liquefied by sonication for 1 min (MSE ultrasonicator,
type 5.65; power set at 100 Watt). Fifty l of the liquefied
agarose was added to 2 ml of the Hoechst dye solution
(0.1 g/ml in 10 mM Tris.HCl, pH 7.4, 1 mM EDTA and
0.2 M NaCl) and fluorescence was measured in a Hoefer
dynaquant 200 fluorometer, using double stranded calf
thymus DNA in liquefied agarose as a standard.
35S-incorporation in aggrecan was investigated using
Na235SO4 as a radioactive precursor. After a 2-week cul-
ture period, 10 Ci/ml of the label was included in the
incubation medium over 48 hours. Newly synthesized
35S-aggrecans partly accumulated in the artificial inter-
cellular agarose matrix. Another part of these
35S-macromolecules escaped to the incubation medium.
The agarose was mechanically disrupted and digested in
the culture dish using 3.0 ml of a 50 U/ml agarase (agarose
3-glycanohydrolase from pseudomonas atlantica; SIGMA)
in 0.067 M phosphate pH 6.0 in the presence of proteinase
inhibitors (0.1 M -amino-n-caproic acid, 0.01 M EDTA,
0.005 M benzamidine chloride and 0.01 M phenylmethyl-
sulphonyl fluoride20) at 40°C overnight. It was shown
previously that 75±3% and 78±2% of the radiolabeled
material was liberated from 0.5 and 1.0% agarose gels,
respectively.17 The resulting suspension was centrifuged.
The supernatant and the incubation medium were pooled
for further chromatography.SYNTHESIS OF AGGRECAN
After centrifugation, aliquots of pools of combined media
and agarose digests were desalted through Sephadex G25
(Pharmacia) chromatography gels in 0.067 M phosphate
(K2HPO4/Na2HPO4) pH 6.8, containing 0.01 M Na2SO4,
in order to separate 35S-labeled aggrecans from free
35Sulfate. The eluted macromolecular fractions were
counted for radioactivity. The radioactivity under the curves
(void volume) is related to the total incorporation of
35Sulfate in aggrecans by the respective cultures. In the
majority of the in-vitro conditions tested so far, most of the
35SO used by phenotypically stable cartilage cells is4
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size proteoglycans such as decorin, biglycan, fibromodulin,
type XI collagen and other physiologically important but
less abundant extracellular macromolecules were not
studied with these approaches.
Considering the amount of pooled culture medium that
ultimately was analysed after chromatography, the specific
activity of the incubation medium, the decay of 35Sulfate,
the labeling period in hours and the numbers of cells per
culture, sulphate incorporation was expressed as pg of SO4
incorporated per 1.106 chondrocytes per hour using the
equation:
V.S/8851: V.S is the 35S-activity in the sample measured as
the area under the chromatography curve and is expressed
in Volt.Sec by the on-line liquid scintillation counter. This
value in Volt.Sec has to be converted into dpm. It was
experimentally established that a standard sample with a
fixed amount of radioactivity: 10,000 dpm (assayed in a
scintillation counter; Tricarb 1500, Hewlett Packard), gave
an area under the chromatography curve of 88,510,000
Volt.Sec. Consequently, 8851 Volt.Sec corresponds to
1 dpm.
The 35S-activity is then converted to pCi of 35Sulfate.
The unit of activity, Curie (Ci) is defined as 3.7×1010 dps
or 222×1010 dpm. Therefore, 1 dpm=0.46 pCi of
35Sulfate.
Knowing the specific activity (sp.act) of the sulfate:
10 Ci 35S/0.78 M SO4 (DMEM with 10% FCS contains
0.78 M of sulfate per ml), and the M.W. of SO4 (96.058 D),
pCi of 35Sulfate was converted to molar concentrations and
further to picograms of ‘cold’ SO4.
The recorded radioactivity is inversely related to the
decay of 35Sulfate, which is defined as 2−period. For
35Sulfate this ‘period’ represents the life of the 35Sulfate
sample divided by the half-life of 35Sulfate (87.5 days).
Finally, CHO are the numbers of chondrocytes (in
1×106) inoculated in the gel, H is the exposure time to
35Sulfate in hours.
This expression of the results allows the reproducibility
of the 35S-incorporation rates to be compared between
different batches of chondrocytes.ANALYSIS OF 35S-AGGRECAN SUBPOPULATIONS
Pools of combined media and agarose digests were
desalted through Sephadex G25 chromatography gels in
order to separate 35S-labeled aggrecans from free
35Sulfate. Fractions containing the 35S-labeled macro-
molecules were pooled and used for gel permeation
chromatography on Sepharose Cl-2B (Pharmacia) in the
same buffer. 35S-labeled macromolecules have been
shown to elute in three fractions: 35S-aggrecan aggregates
and monomers separated from each other in the first two
peaks.17,21 Some low molecular weight material, the exact
nature of which has not been investigated (breakdown
products; low hydrodynamic size aggrecan subpopulations)
eluted in the third tailing fraction. The radioactivity
under the first two curves allowed the proportions of
35S-aggrecan aggregates and monomers to be calculated.Electron microscopic study of aggrecan aggregates was
done on the macromolecules synthesized by the chondro-
cytes obtained from eight different donors with increasing
ages. The chondrocytes were maintained in agarose gels
for 3 weeks after which the accumulated aggrecans were
isolated after digestion of the agarose gel with the agarase
solution at 40°C overnight. It was previously shown that the
agarase did not affect either the hyaluronan or the aggre-
can molecules.13 Solubilization of the artificial matrix
allowed native aggrecan aggregates, monomeric aggrecan
and other proteoglycan subtypes to be obtained. In a series
of 12 experiments, 85.6±9.6% of the 35S-aggrecan aggre-
gates, 53.9±21.% of the 35S-aggrecan monomers and
41.3±17.6% of the low molecular weight proteoglycans
were shown to be immobilized in 1.5% of agarose.22 The
culture media were not used. The resulting solution was
centrifuged at 300 g for 10 min to precipitate the cells. The
supernatant containing the liberated aggrecans was stored
at −20°C until use.PREPARATION OF THE AGGRECANS FOR ELECTRON MICROSCOPY
A modification of the Kleinschmidt protein monolayer
technique23 was used for visualization of the aggrecans.
The procedure has been described in detail.13 Depending
on the concentration of the aggrecans, the supernatant was
first diluted with phosphate buffer (0.1 M KCl, 0.02 M
KH2PO4; pH 7.0) in order to obtain well identifiable mol-
ecules on the electron microscope screen. Ten l of this
aggrecan containing solution was then mixed with 10 l
0.05 M Tris HCl; pH 8.5, containing 0.005 M EDTA, 10 l of
6M NH4-acetate, 10 l of 2 mg/ml cytochrome C and 10 l
of distilled water. This solution is referred to as the hyper-
phase and was kept on ice before being slowly released on
0.25 M NH4-acetate (the hypophase of which the surface
has been cleaned with a glass or teflon bar). Thirty l of the
hyperphase was slowly released on an alcohol-cleaned
glass slide partially immersed in the hypophase and mak-
ing an angle of 30° with the surface of this hypophase. The
hyperphase, containing the aggrecans and cytochrome C,
is spread over the surface of the hypophase and forms a
monomolecular layer. The boundaries of this layer are
indicated by talcum powder, a small amount of which had
been dusted onto the surface of the hypophase at the
immersion area of the slide.
The aggrecan-cytochrome C film was then picked up
with copper grids previously coated with 1% nitrocellulose
in amylacetate and immediately immersed for 60 seconds
in a freshly prepared staining solution (0.05 M uranyl
acetate in 0.05 M HCl/90% alcohol: 1/1000 v/v). The grids
were then allowed to dry on a filter paper and finally
shadowed with platinum-palladium (80:20) at an angle of 7°
and a distance of 10 cm with a Jeol JEE 4B vacuum
evaporator. Electron microscopy was performed with a Jeol
1200 EX II which allows direct observation on a fluorescent
screen. The number of attached monomers per aggrecan
aggregate was counted for 100–300 observed complexes.
Twenty aggrecan aggregates synthesized by the chondro-
cytes of three donors (2 months, 30 and 64 years of age)
and carrying nine to 76 aggrecans were selected at random
to measure hyaluronan backbone chain lengths and to
count the numbers of attached aggrecans. These variables
enabled the space (nm) between the immobilized
aggrecans to be calculated.
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Chondrocyte numbers (DNA content) in the agarose
cultures were assayed in four-fold. 35S-incorporation exper-
iments to evaluate aggrecan synthesis rates and the pro-
portions of aggrecan in aggregates, and the electron
microscopic studies of the aggrecan aggregates, were
done in three cultures from each of the donors as specified.
Mean values and 1SD were calculated. Student’s t-tests
were used to examine whether these variables were sig-
nificantly different in the respective chondrocyte cultures.
Regression analysis was used to find possible correlations
between observed variables and the age of the donors.ResultsPROLIFERATION OF CHONDROCYTES IN 1.5% AGAROSE
On average, a 13.6% (range: 3–26%) decrease in DNA
content occurred within the first week of chondrocyte cul-
ture, indicating that a proportion of the cells did not survive
the inoculation procedure. The drop in the amounts of DNA
after 1 week was significant in most of the batches. This
loss of cells is inherent to this type of manipulations.16 The
age of the donor did not influence the loss of the cells in
culture.
No significant decreases in cell numbers were observed
during another week in culture. Increases in DNA content,
indicating chondrocyte proliferation were not observed
in this 1.5% of agarose. Chondrocytes of one donor
(‘M0’), when maintained in 0.5% of agarose, were able to
proliferate (Table I).AGGRECAN SYNTHESIS RATES
The chondrocytes obtained from 33 successive
autopsies were isolated and cultured. The ages of the
donors ranged between 2 and 69 years. Synthesis of
aggrecans was investigated using Na235SO4 as a radio-
active precursor. The incorporation of SO4 was expressed
as pg of SO4 incorporated in aggrecan macromolecules per
1.106 chondrocytes per hour. Sulfate incorporation rates
into aggrecans correlated inversely with the age of the
donor (Fig. 1). Regression analysis of SO4-incorporation
versus age showed that the best fitting curve for the 33
experiments performed corresponded to the exponential
function: Y=exp (a+bX) or: Y=2.7183(9.830–0.029X). This
equation allowed a theoretical value of sulfate incorporation
in aggrecans for chondrocytes obtained from mature carti-
lage of a 20-year-old individual in this system to be calcu-
lated at 10,406 pg/1.106 inoculated cells/hour. This value
drops to 50% and 25% for chondrocytes obtained from 45
and 69-year-old individuals, respectively. Although sulfate
incorporation rates in vitro do not allow extrapolation to
aggrecan synthesis rates in tissues in vivo, the trend of an
impaired aggrecan production in an aging population is
obvious.Fig. 1. Synthesis of aggrecans related to the age of the donor
(n=33). The incorporation of SO4 was expressed as pg of SO4
incorporated in aggrecans per 1.106 chondrocytes per hour.
Correlation coefficient: −0.662; Squared R: 0.44%. Solid line:
regression line; broken line: 95% confidence interval.AGGRECAN SUBPOPULATIONS
Sepharose Cl-2B gel permeation chromatography was
performed on the pools of combined agarose digests and
supernatant media obtained from the cultures of 19 donors,
their ages ranging from 25 to 64 years. Proportions of
aggrecan in aggregates and in monomeric form and of lowmolecular weight proteoglycan are listed in Table II. As
specified, the 35S-labeled material from three cultures from
each donor was analysed. Coefficients of variation of the
results illustrate the high reproducibility of the system.
Relative amounts of aggrecan in aggregate and in mono-
mer form ranged from 29 to 46% (36.3±4.5%) and from 31
to 44% (39.7±3.8%), respectively. Regression analysis of
the proportions of aggrecan aggregates and the age of the
donors showed no correlation between these two variables
(Fig. 2).
Electron microscopic study of aggrecan aggregates was
done on the macromolecules synthesized by the chondro-
cytes obtained from eight different donors between 2
months and 64 years of age. Aggrecans, accumulated
during culture, were liberated by agarase digestion of
the artificial agarose matrix and studied by electron
microscopy. Aggrecans were observed as free molecules
or attached on hyaluronan chains. In these aggregates no
free binding sites on the hyaluronan chain were observed.
‘De novo’ synthesized hyaluronan molecules were fully
loaded with aggrecans, and consequently the molecular
size of the aggregate was defined by the length of the
hyaluronan chain (Fig. 3).
Frequency distribution histograms were made showing
the number of aggregates with a given number of aggre-
cans per aggregate. Some of the frequency distribution
histograms showing the molecular size distribution of the
aggrecan aggregates produced by the cartilage cells
obtained from different individuals with ascending ages
were represented in Fig. 4.
Mature human articular cartilage cells were found to
accumulate an aggrecan aggregate which carried 11.7 to
13.1 aggrecans on average. Cells obtained from immature
donors synthesized aggrecan aggregates of which the
hyaluronan chain carried two to three times this amount of
aggrecans (Table III). These immature human articular
cartilage cells were also found to synthesize significant
proportions of large aggrecan aggregates with 20 to over
100 aggrecans attached to a single hyaluronan chain.
Regression analysis showed that both the average number
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large aggrecan aggregates with more than 20 aggrecans
bound to one single hyaluronan chain decreased with
increasing age of the donors of the chondrocytes (Table III).
Spacing between the aggrecans attached on the
hyaluronan filament was calculated on three samples of 20
randomly selected aggregates synthesized by the chondro-
cytes of three donors. Obviously, increased packing of
aggrecan in an aggregate was not primarily caused by a
decrease in spacing between the aggrecan attachment
points (Fig. 5, insets). Differences in spacing between the
immobilized aggrecans were related to the age of the donor
(Table IV). The decrease in spacing between the aggre-
cans increased the number of packed aggrecans on a
1000 nm hyaluronan filament by approx. Thirty % in the
aggregates produced by immature chondrocytes. However,
this difference could not contribute to a two to three-fold
increase in the hydrodynamic size of the average aggre-
gate. Hence, the amount of aggrecans immobilized in anaggregate was primarily defined by the length of the
hyaluronan chain.Table I
Survival and proliferation of chondrocytes in 1.5% agarose-g of DNA per culture
Weeks in culture 0 1 2
Donor Mean±1 SD Mean±1 SD Change Mean±1 SD Change
Fetal 10.8±0.5 8.6±0.3 −20.4% (3) 11.5±0.4 +6.5% (2)
M 0 11.6±0.5 10.7±0.4 −7.8% n.s 9.4±0.5 −19.0% n.s
M 0* 14.6±0.1 15.6±0.4 +6.8% n.s 18.6±0.2 +27.4% (4)
M 19 8.5±0.3 n.d. — 6.9±0.2 −18.8% (1)
M 33 6.6±0.2 6.4±0.4 −3.0% n.s 6.0±0.6 −9.0% n.s
F 44 12.8±0.6 9.5±0.6 −25.8% (1) 9.9±0.5 −22.7% n.s
M 61 11.0±0.5 9.8±0.2 −10.9% (1) 9.5±0.2 −13.6% n.s
Mean±1 SD −13.6±9.3% −12.8±10.6%
Donor: sex and age are given; levels of significance: n.s: not significant; (1): P<0.05; (2): P<0.01; (3): P<0.002;
(4): P<0.004.
*Chondrocytes cultured in 0.5% agarose.Table II
Incorporation of 35Sulfate in aggrecan aggregates, monomeric
aggrecan and low molecular weight proteoglycans
Donor % Aggr. % Mono % Low MW
M 25 35 (7) 31 (2) 34 (7)
M 36 38 (2) 41 (3) 21 (8)
F 39 33 (5) 40 (2) 27 (6)
M 42 29 (43) 44 (6) 27 (43)
M 42 29 (13) 44 (3) 27 (12)
M 55 33 (6) 36 (4) 31 (8)
M 55 34 (1) 43 (1) 23 (2)
M 55 36 (3) 44 (1) 20 (4)
F 56 37 (21) 36 (24) 27 (83)
M 56 31 (3) 38 (2) 31 (3)
F 56 37 (8) 36 (9) 27 (22)
F 56 38 (8) 38 (3) 24 (9)
M 57 42 (5) 36 (2) 22 (8)
M 58 42 (1) 44 (5) 14 (14)
M 58 46 (3) 43 (1) 11 (8)
M 59 36 (7) 39 (3) 25 (8)
F 59 42 (8) 37 (3) 21 (13)
M 64 36 (3) 42 (3) 22 (6)
M 64 36 (1) 43 (4) 21 (9)
Mean±1 SD 36.3±4.5 39.7±3.8 23.9±5.6
Donor: sex and age. % of proteoglycan subpopulations: mean
values and coefficients of variation (1 SD×100/mean) are given.Fig. 2. Regression analysis of the proportions of aggrecan aggre-
gates and the age of the donor of the chondrocytes. solid line:
regression line; broken line: 95% confidence interval.IMMOBILIZATION OF AGGRECANS IN THE EXTRACELLULAR MATRIX
Immature cells immobilized far more aggrecans in larger
aggregates. The observations made allowed the number of
aggrecans immobilized by each 100 hyaluronan back-
bones around the chondrocytes in vitro to be calculated.
The fact that these cells synthesized increased proportions
of hyaluronan chains carrying more than 20 aggrecans is of
physiological importance. It is obvious that the aggrecans
accumulated in large hydrodynamic size aggregates in
particular will remain immobilized in the extracellular
environment. Regression analysis showed that both the
cumulated numbers of aggrecans immobilized in each 100
aggregates and in the respective proportions of the large
aggregates (more than 20 aggrecans per aggregate)
decrease after reaching maturity in an aging population
(Table V). In particular, the immobilization of aggrecans in
large aggregates decreases with the age of the donor.
Osteoarthritis and Cartilage Vol. 8 No. 3 175Fig. 3. Electron microscopic appearance of the aggrecan aggre-
gate. Different sizes of aggrecan aggregates were observed.
Spacebar: 200 nm.Fig. 4. Frequency distribution histograms showing the number of
aggregates with a given number of aggrecans per aggregate
(aggregate size). The ages of the donors are represented in the
histograms.Discussion
Human articular chondrocytes cultured in gelled agarose
were shown to synthesize cartilage-specific collagen16
and extracellular matrix aggrecans of which the glycos-
aminoglycan population consisted of chondroitin sulfate
and keratan sulfate. Dermatan sulfate was not found.17,24
Free hyaluronan chains were not detected in this in vitro
system.17 These findings indicated that the cells were
maintained in a phenotypically stable state in this ex vivo
condition.
Chondrocytes obtained from fetal, immature or mature
cartilages did not differ where survival or proliferation in
1.5% agarose are concerned. DNA measurements on
chondrocyte cultures showed that an average of 13.6% of
the chondrocytes did not survive the first week of culture. It
has been reported that about 20% of chondrocytes do not
survive the transition to agarose gels.16 The loss of cells
when transferred from one culture condition to another is
inherent to this type of manipulations.
However, cell numbers remained stable during a second
week in agarose. Cell proliferation—as observed in lower
concentrations of agarose—did not occur in 1.5% of the
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Electron microscopy of aggrecan aggregates. Molecular sizes
Age Nr aggrecans/aggregate % large aggregates
(>20 aggr./aggr.)Sex Median Mean Range Counted
0* F 16 22.9 5–231 200 31.0%
2 M 17 24.5 5–265 300 39.5%
8 M 15 19.3 5–107 100 27.8%
30 M 9 13.1 3–105 300 19.0%
35 M 7 10.2 3– 95 100 4.0%
50 M 9 13.1 3–103 300 13.3%
62 F 9 11.7 3–73 200 11.0%
64 M 8 11.7 3–109 300 8.0%
Mean number aggrecans/aggregate versus age: regression analysis: y= −0.19× +21.7; correlation coefficient:
−0.870; squared R: 75.8%; P-value: 0.005.
% of large aggregates versus age: regression analysis: y= −0.41× +32.1; correlation coefficient: −0.858;
squared R: 73.7%; P-value: 0.006.
*2 months.gel. 0.5% of agarose is the original concentration that has
been used by most researchers. Previous investigations
with this low concentration of gelled agarose showed that
major proportions of the newly synthesized aggrecan
aggregates were not immobilized in the immediate environ-
ment of the chondrocytes and escaped from the matrix.17
Therefore, especially for the study of cell-matrix inter-
actions, higher (1.5%) concentrations of the agarose, from
which aggrecan aggregates do not escape, have been
used in this laboratory. Characteristically, cell replication
and cluster formation were never observed in these con-
centrated agarose gels. This explains the lack of ‘cell
recovery’ after prolonged culture time. The maintenance of
a constant cell number in concentrated agarose is an
advantage especially in these experimental procedures
where age-dependent cell proliferation would have biased
the results of 35S-incorporation/culture.
One part of a batch of ‘new-born’ chondrocytes was
seeded in 0.5% agarose. These cells readily started to
proliferate. No decreases in cell numbers were observed in
this experiment and after 2 weeks the cell numbers
exceeded the baseline values. Of the same batch of
chondrocytes, 20% of the chondrocytes were lost after the
inoculation procedure in 1.5% agarose where they did not
proliferate.
Viability was not tested after completion of the
35S-incorporation experiments. However, using flow
cytometry of propidium iodide stained chondrocytes liber-
ated from agarase-digested agarose gels, it was shown
that about 90% of the cells isolated from 1.5% of agarose
were viable after prolonged culture (results not shown).
‘De novo’ synthesis of proteoglycans was assayed as
35S-activity in macromolecules eluting in the void volume of
a G25-Sephadex gel filtration experiment. By far the
greater part of the 35SO4 in these experiments is incorpor-
ated in aggrecans and any age-dependent variations in the
synthesis of minor proteoglycans are unlikely to interfere
with the assessment of aggrecan synthesis. Aggrecan
synthesis, expressed as SO4-incorporation rates per 1.106
inoculated cells per hour, correlates with the age of
the donor. The 75–80% of the newly synthesized
35S-aggrecans which were recovered from the agarose17
represent interterritorial matrix material. 20–25% of the
35S-activity (cell-associated) were not considered in this
procedure. Higher aggrecan synthesis rates by cells
obtained from younger donors did not reflect higher cell
numbers in agarose after 2 weeks of culture. Regressionanalysis of SO4-incorporation versus age showed that the
best fitting curve for the experiments performed corre-
sponded to an exponential function which made it possible
to estimate the decrease of aggrecan synthesis rates in an
aging population after reaching maturity. Others have found
that aggrecan synthesis rates decline with aging in carti-
lage tissue culture.1–4 The results of these experiments do
not allow extrapolation to in vivo synthesis rates. However,
it may be assumed that articular cartilage cells keep their
age-related in vivo synthesis properties in this culture
condition.
Sepharose Cl-2B gel chromatography patterns have
allowed the relative amounts of aggrecan aggregates and
monomeric aggrecan released in the culture system to be
defined.21 The relative amounts of aggrecans present in
aggrecan aggregates varied between 29 and 46% and did
not change with age. Decreasing aggrecan synthesis rates
with unvarying proportions of aggrecan aggregates may
indicate an impaired hyaluronan synthesis in an aging
population. Hyaluronan and aggrecan were shown to have
the same turnover times in bovine articular cartilage.25
Only part of the aggrecans form aggrecan aggregates
with hyaluronan, whereas other aggrecan molecules
remain in the monomeric condition. It was previously
shown that approximately 86% of the newly synthesized
aggrecan aggregates are immobilized in this 1.5% agarose
gel and remain in the immediate vicinity of the chondro-
cyte.17,22 Aggrecans, accumulated during culture, were
liberated by agarase digestion of the artificial agarose
matrix and studied by electron microscopy.
The culture system and the specific method used to
liberate the extracellular matrix macromolecules has
enabled us to study the whole population of de novo
synthesized, native aggrecan aggregates.13 An excess of
aggrecans was observed in the monomeric form. This was
already evident from the Cl-2B gel permeation exper-
iments showing significant proportions of monomeric
35S-aggrecan. Another part of the newly synthesized
aggrecans is stabilized on hyaluronan. Spacing between
aggrecan attachment points did not vary to a large extent
and was within the same range as described previously:
26–27 nm.13 The aggrecans were uniformly distributed on
the hyaluronan filament. In the aggregates, no free binding
sites on the hyaluronan chain were observed. It is unlikely
that collapse of hyaluronan chains would systematically
occur in areas of the chain where packing of aggrecans
was incomplete.
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chain length and of spacing between immobilized aggrecans on
the number of aggrecans in an aggregate. Main graphs: regression
analysis of number of immobilized aggrecans against hyaluronan
filament length. Abcissae: hyaluronan chain length (nm); Ordi-
nates: number of immobilized aggrecans. Right upper corner: age
of the donor. Correlation coefficients: 0, 30 and 64 years: 0.975,
0.952 and 0.954, respectively. Inserted graphs: spacing between
attached aggrecans as related to aggregate size (number of
aggrecans per aggregate). Abcissae: number of aggrecans in an
aggregate. Ordinates: space (nm) on the hyaluronan chain
between immobilized aggrecans.Table IV
Spacing between immobilized aggrecans on the hyaluronan filament
Age Sex Hyaluronan
chain length
range
No. aggrecans
attached
range
Spacing between
aggrecans (nm)
Mean±1 SD Range
0* F 200–1720 9–76 22.56±4.48 13.6–29.6
30 M 200–1100 9–35 25.09±5.66† 16.7–36.4
64 M 260–1350 10–40 25.86±4.83‡ 19.2–36.1
*2 months; hyaluronan chain length and spacing between aggrecans expressed in nm; †0 versus 30 years: not
significant; ‡0 versus 64 years: P-value=0.031 (Student’s t-test).Table V
Immobilization of aggrecans in 100 aggregates and in the large
molecular size aggregates
Age Sex In 100
aggregates
In the large**
aggregates out
of 100 aggregates
0* F 2292 1424
2 M 2453 1706
8 M 1913 1116
30 M 1307 566
35 M 1015 237
50 M 1311 518
62 F 1168 329
64 M 1172 365
*2 months; **>20 aggrecans/aggregate; numbers of aggrecans
in 100 aggregates versus age: regression analysis: y= −19.6× +
2161.7; correlation coefficient: −0.867; squared R: 75.2%;
P-value: 0.005.
Number of aggrecans in large aggregates versus age: regres-
sion analysis: y= −18.7× +1370.6; correlation coefficient: −0.878;
squared R: 77.0%; P-value: 0.004.A minimum of five hyaluronan disaccharide units (MW:
about 1800 D) is required to bind an aggrecan26,27 and this
binding region should extend to approximately 4.5 nm.28
An adjacent region of the hyaluronan chain is occupied by
link glycoprotein. Chondroitin sulfate chains contain about
25–30 disaccharide units on average. Their molecular
weight is estimated at 11,500–14,000 D29,30 giving chain
lengths of 25–30 nm. If aggrecans sat down side-by-side
on a hyaluronan chain in a two-dimensional plane, steric
hindrance due to the span of the chondroitin sulfate
chains would determine a minimum distance that aggre-
cans can approach one another, being 50–60 nm. How-
ever, since they expand in the three dimensions on a
hyaluronan chain, the width of the aggrecan probably does
not determine the minimum distance between aggrecans.
It is suggested that the 26–27 nm distance observed
between aggrecan attachment points is the minimum poss-
ible. Hyaluronan chains in the observed aggregates have
therefore been considered to be fully loaded.
A slightly increased spacing of the aggrecan molecules
with age may reflect the decrease in affinity for hyaluronan
of the aggrecan hyaluronan-binding region in aging sub-
jects.31 Furthermore, the concentration of link protein sig-
nificantly influences aggregation, aggregate stability, and
uniformity of aggrecan spacing. Declines in the concen-
tration of link protein significantly decreased aggregation,
the size and stability of aggregates, and the regularity of
aggrecan spacing.32 Although link protein concentrations
were not measured in these experiments, the uniform and
regular spacing made it conceivable that sufficient link
protein was available to stabilize the aggregates. When
178 G. Verbruggen et al.: Articular cartilage aggrecans and agingcultured in conditions allowing the maintenance of their
original phenotype, chondrocytes indeed synthesize the
macromolecules that make up the aggrecan aggregate in a
coordinated manner thereby retaining the relative amounts
of each component of this macromolecular complex.32–35
We therefore assume that the molecular size of the
aggregate was defined by the length of its hyaluronan
backbone.
The average aggrecan aggregate produced by an
immature chondrocyte carried two to three times as much
aggrecans as the aggregate synthesized by a mature
human articular cartilage cell. Furthermore, immature
human articular cartilage cells were found to accumulate
significant proportions of large aggrecan aggregates with
over 20 to more than 100 aggrecans attached to a single
hyaluronan chain. There was a three to four-fold decrease
in the proportions of the large aggrecan aggregates with
increasing age of the donors of the chondrocytes. Conse-
quently, there is impaired immobilization of aggrecans in
the extracellular environment of aging mature cartilage.
The length of the hyaluronan backbone determines the
hydrodynamic size of the aggregate and therefore immobi-
lization and accumulation of the aggrecans in the extra-
cellular matrix. Hyaluronan is initially synthesized as large
macromolecules that are gradually depolymerized with
time within the extracellular matrix.25 The largest aggre-
gates produced by mature and immature chondrocytes in
agarose carried 100–250 aggrecans, respectively. Consid-
ering the distance between the aggrecan attachment
points, hyaluronan filament lengths of 2700–6750 nm have
been calculated. Assuming a molecular weight of 379 D
and a length of 1 nm for the repeating hyaluronan di-
saccharide unit,28 such filament lengths correspond to
hyaluronan molecular weights of 1023–2558 kD. These
figures agree with those reported for hyaluronan produced
by chondrocytes.36
Although age-related changes in the size of the newly-
synthesized hyaluronan chains were not detected, articular
cartilage hyaluronan molecular weight was shown to
decrease proportionally between 2.5 and 86 years of
age.36 It has been suggested that oxygen-derived radi-
cals may be implicated in the random fragmentation of
the hyaluronan molecule.25 Considering the age-related
decrease in affinity of the aggrecan monomers for hyaluro-
nan,31,37 it will take more time for hyaluronan in mature
cartilage to become surrounded by free radical scavenging
aggrecans. In aging cartilage, the process of random
fragmentation of the free hyaluronan macromolecule by
oxygen radicals may be more effective and may result in
the presence of shorter hyaluronate chains on which the
aggrecans will be immobilized.
The declining aggrecan synthesis rates and the
decreased capability of synthesizing large molecular size
aggregates with increasing age in humans illustrates a
progressive failure of the repair function of articular carti-
lage cells in humans and may be related to a predisposi-
tion to tissue degeneration. This observation may in part
account for the increasing incidence and progression of
osteoarthritis in an aged population. These experiments
were obviously done with isolated cells liberated from any
possible environmental influence. Extrapolation to the in
vivo condition should not been made unreservedly. The
exposure of chondrocytes to changing environmental
conditions with age, e.g. varying matrix architectures
and tissular concentrations of growth and differentiation
factors, could influence the production and retention of
matrix macromolecular compounds.References
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